Chronic lymphocytic leukemia in the elderly population

Clinics in Geriatric Medicine

Volumn 13, Issue 2, 1997, Pages 245-249

  Rai, K R ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CLADRIBINE; COTRIMOXAZOLE; FLUCONAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; NUCLEOSIDE ANALOG; PREDNISONE;

AGED; AUTOIMMUNITY; BONE MARROW SUPPRESSION; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; DRUG THERAPY; GERIATRIC DISORDER; HUMAN; IMMUNOPHENOTYPING; OPPORTUNISTIC INFECTION; PROGNOSIS; REVIEW; STEROID THERAPY;

EID: 0030958045     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0749-0690(18)30167-8     Document Type: Review

References (5)

1. Cheson B. Bennett J.M. Grever M. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment Blood 87 1996 4990
2. International Workshop on CLL Chronic Lymphocytic Leukemia: Recommendations for diagnosis, staging and response criteria Ann Intern Med 110 1989 236
3. K.R. Rai M. Keating Chronic lymphocytic leukemia Holland J.F. Frei E. III Bast R.C. Jr Cancer Medicine, ed 2 1997 Williams & Wilkins Baltimore 2697
4. Rai K.R. Peterson B. Elias L. A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia: A CALGB, SWOG, CTG/NCIC and ECOG Intergroup Study Blood 88 1996 141a
5. Ries LAG, Miller BA, Hankey BF, et al (eds): SEER Cancer Statistics Review 1973-1991: Tables and Graphs, National Cancer Institute, 1994. Bethesda, NIH Pub No. 94-2789